Matches in Wikidata for { <http://www.wikidata.org/entity/Q60453040> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q60453040 description "im Januar 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q60453040 description "wetenschappelijk artikel" @default.
- Q60453040 description "наукова стаття, опублікована у 2011" @default.
- Q60453040 name "A new series of ferrocifen derivatives, bearing two aminoalkyl chains, with strong antiproliferative effects on breast cancer cells" @default.
- Q60453040 name "A new series of ferrocifen derivatives, bearing two aminoalkyl chains, with strong antiproliferative effects on breast cancer cells" @default.
- Q60453040 type Item @default.
- Q60453040 label "A new series of ferrocifen derivatives, bearing two aminoalkyl chains, with strong antiproliferative effects on breast cancer cells" @default.
- Q60453040 label "A new series of ferrocifen derivatives, bearing two aminoalkyl chains, with strong antiproliferative effects on breast cancer cells" @default.
- Q60453040 prefLabel "A new series of ferrocifen derivatives, bearing two aminoalkyl chains, with strong antiproliferative effects on breast cancer cells" @default.
- Q60453040 prefLabel "A new series of ferrocifen derivatives, bearing two aminoalkyl chains, with strong antiproliferative effects on breast cancer cells" @default.
- Q60453040 P1433 Q60453040-EB23A8F9-EEE7-40B7-874B-2B8EA4ADEFD9 @default.
- Q60453040 P1476 Q60453040-C2F0E8E5-8B47-4018-8557-63AF4CA37E3A @default.
- Q60453040 P304 Q60453040-3B361967-1ACA-40D4-843C-1C8360799752 @default.
- Q60453040 P31 Q60453040-61B23A9E-D561-4839-82E8-EE5C4DFDB221 @default.
- Q60453040 P356 Q60453040-1A6EB4AF-C5B4-4348-820A-D7335DE6B1FA @default.
- Q60453040 P433 Q60453040-DB81A885-5EEE-48A2-B0B2-5B421EC57FD4 @default.
- Q60453040 P478 Q60453040-5FAE646A-824F-4761-8BC3-D3641BAC6502 @default.
- Q60453040 P50 Q60453040-027404FD-472F-4656-A109-EEA53737DB6E @default.
- Q60453040 P50 Q60453040-09456170-8702-4F9D-9087-B03AD76324F0 @default.
- Q60453040 P50 Q60453040-094722F7-3A27-41FF-B1A0-3D592529FEF9 @default.
- Q60453040 P50 Q60453040-164CDF57-FEAD-45A5-AA1C-EA38075DDC0F @default.
- Q60453040 P50 Q60453040-178880F9-ACA0-42B5-B927-9187B89DD686 @default.
- Q60453040 P50 Q60453040-51900A67-A455-4CA1-A829-4373B629B7AF @default.
- Q60453040 P50 Q60453040-5EFADEBD-8A16-45D6-B7BD-49F86D728C1A @default.
- Q60453040 P50 Q60453040-BF69CB3C-9829-4715-A114-CD9F28CF8FA5 @default.
- Q60453040 P50 Q60453040-E4B219CB-3073-4680-8ACC-30362CC13AC9 @default.
- Q60453040 P577 Q60453040-4A47FCE9-F410-4AB8-AD28-17D278F5A90A @default.
- Q60453040 P356 C1NJ20192A @default.
- Q60453040 P1433 Q3338971 @default.
- Q60453040 P1476 "A new series of ferrocifen derivatives, bearing two aminoalkyl chains, with strong antiproliferative effects on breast cancer cells" @default.
- Q60453040 P304 "2212" @default.
- Q60453040 P31 Q13442814 @default.
- Q60453040 P356 "10.1039/C1NJ20192A" @default.
- Q60453040 P433 "10" @default.
- Q60453040 P478 "35" @default.
- Q60453040 P50 Q117269872 @default.
- Q60453040 P50 Q117269873 @default.
- Q60453040 P50 Q117269876 @default.
- Q60453040 P50 Q33268747 @default.
- Q60453040 P50 Q53738953 @default.
- Q60453040 P50 Q57068278 @default.
- Q60453040 P50 Q60006911 @default.
- Q60453040 P50 Q60007435 @default.
- Q60453040 P50 Q60007449 @default.
- Q60453040 P577 "2011-01-01T00:00:00Z" @default.